Furthermore, the down-regulation of LC3B, Beclin-1, and ATG5, and the up-regulation of SQSTM1 were detected in CDDP-resistant GC cells after Ubenimex treatment (Figure 7D–7F). The gene discussed is ATG5; the disease is gastric cancer.